Roche provides update on phase III studies of etrolizumab in people with moderately to severely active ulcerative colitis
Basel, 10 August 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced topline results from its phase III study programme evaluating the investigational medicine etrolizumab in people with moderately to severely active ulcerative colitis. Mixed results were seen in studies evaluating etrolizumab as an induction therapy, and both studies evaluating etrolizumab as a maintenance therapy failed to meet their primary endpoints, showing no significant difference in the proportion of people achieving remission with subcutaneous etrolizumab versus placebo. In the HIBISCUS I induction study, in people without prior anti-tumour ...
Source: Roche Media News - August 10, 2020 Category: Pharmaceuticals Source Type: news
Dataset on the global patent networks within and between vehicle powertrain technologies - cases of ICEV, HEV, and BEV - Mirzadeh Phirouzabad A, Savage D, Juniper J, Blackmore K.
This article contains the data... (Source: SafetyLit)
Source: SafetyLit - January 13, 2020 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news
Siemens unveils Acuson Redwood ultrasound scanner
Siemens Healthineers has introduced Acuson Redwood, a shared-services ultrasound...Read more on AuntMinnie.comRelated Reading:
Siemens buys healthcare strategy firm
Siemens gets FDA clearance for AI chest CT software
Siemens launches Acuson Sequoia in Canada
Siemens launches Juniper ultrasound scanner in Canada
Siemens goes back to future with Acuson Sequoia launch (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 14, 2019 Category: Radiology Source Type: news
Siemens launches Acuson Sequoia in Canada
Siemens Healthineers has begun selling its Acuson Sequoia ultrasound scanner...Read more on AuntMinnie.comRelated Reading:
FDA clears Siemens 3T Lumina MRI scanner
Siemens posts moderate revenue growth in Q1
Siemens wins FDA clearance for Multix Impact DR unit
Siemens launches Juniper ultrasound scanner in Canada (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 4, 2019 Category: Radiology Source Type: news
FDA clears Siemens 3T Lumina MRI scanner
Siemens Healthineers has received clearance from the U.S. Food and Drug Administration...Read more on AuntMinnie.comRelated Reading:
Siemens posts moderate revenue growth in Q1
Siemens wins FDA clearance for Multix Impact DR unit
Siemens launches Juniper ultrasound scanner in Canada
RSNA 2018 Video Roundup: Siemens Healthineers
Siemens releases new MRI, AI for CT, and x-ray systems at RSNA (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 30, 2019 Category: Radiology Source Type: news
Siemens posts moderate revenue growth in Q1
Higher CT and molecular imaging sales helped Siemens Healthineers achieve moderate...Read more on AuntMinnie.comRelated Reading:
Siemens wins FDA clearance for Multix Impact DR unit
Siemens launches Juniper ultrasound scanner in Canada
RSNA 2018 Video Roundup: Siemens Healthineers
Siemens releases new MRI, AI for CT, and x-ray systems at RSNA
Siemens launches new MRI scanners in BioMatrix family (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 29, 2019 Category: Radiology Source Type: news
Siemens wins FDA clearance for Multix Impact DR unit
Siemens Healthineers has garnered U.S. Food and Drug Administration (FDA) clearance...Read more on AuntMinnie.comRelated Reading:
Siemens launches Juniper ultrasound scanner in Canada
RSNA 2018 Video Roundup: Siemens Healthineers
Siemens releases new MRI, AI for CT, and x-ray systems at RSNA
Siemens launches new MRI scanners in BioMatrix family
Currency changes hurt Siemens Healthineers numbers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 22, 2019 Category: Radiology Source Type: news
Siemens launches Juniper ultrasound scanner in Canada
Siemens Healthineers has launched the Acuson Juniper ultrasound scanner in...Read more on AuntMinnie.comRelated Reading:
RSNA 2018 Video Roundup: Siemens Healthineers
Siemens releases new MRI, AI for CT, and x-ray systems at RSNA
Siemens launches new MRI scanners in BioMatrix family
Currency changes hurt Siemens Healthineers numbers
Siemens wins FDA nod for Cios Spin mobile C-arm (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 4, 2019 Category: Radiology Source Type: news
Temple hires financial advisor as it explores possible sale of 2 hospitals
Temple University announced Monday it has retained the services of Juniper Advisory to pursue strategic options for Temple University Health System, which include the possible sale of Fox Chase Cancer Center, neighboring Jeanes Hospital or both.
The move comes about a month-and-a-half after Temple's Board of Trustees announced it had authorized a series of steps aimed at strengthening the health system's finances and "preserve its ability to serve its mission." One of those steps was authorizing… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 6, 2018 Category: American Health Authors: John George Source Type: news
Temple hires financial advisor as it explores possible sale of 2 hospitals
Temple University announced Monday it has retained the services of Juniper Advisory to pursue strategic options for Temple University Health System, which include the possible sale of Fox Chase Cancer Center, neighboring Jeanes Hospital or both.
The move comes about a month-and-a-half after Temple's Board of Trustees announced it had authorized a series of steps aimed at strengthening the health system's finances and "preserve its ability to serve its mission." One of those steps was authorizing… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 6, 2018 Category: Biotechnology Authors: John George Source Type: news
Catalent acquiring Boston's Juniper Pharmaceuticals for $128M
Drug contract manufacturer Catalent has agreed to acquire Boston-based Juniper Pharmaceuticals for $128 million, the companies announced.
Under the deal, New Jersey-based Catalent (NYSE: CTLT) will acquire all of Juniper’s (Nasdaq: JNP) shares for $11.50 per share. That values Juniper at a 60 percent premium to its share price on Jan. 30, the last trading day before the company announced that it was exploring a potential sale.
Ju niper provides drug development and manufacturing services to other… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 6, 2018 Category: Pharmaceuticals Authors: Max Stendahl Source Type: news
Catalent expands early-phase development skills with $139m Juniper buyout
Catalent (NYSE:CTLT) said today that it inked a $139 million deal to acquire Juniper Pharmaceuticals (NSDQ:JNPR) and its early-stage product development services.
The company noted that its Juniper acquisition, set at $11.50 per share, will complement Catalent’s formulation development offerings, bioavailability solutions and clinical-scale oral dose manufacturing capabilities.
Get the full story at our sister site, Drug Delivery Business News.
The post Catalent expands early-phase development skills with $139m Juniper buyout appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 3, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Mergers & Acquisitions Pharmaceuticals Research & Development Wall Street Beat Catalent Source Type: news
Juniper Pharmaceuticals Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash
BOSTON, July 3, 2018 -- (Healthcare Sales & Marketing Network) -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), a diversified healthcare company with core businesses of its CRINONE® (progesterone gel) franchise and fee-for-service contract development ... Biopharmaceuticals, Mergers & Acquisitions Juniper Pharmaceuticals, Catalent , CRINONE, progesterone gel (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 3, 2018 Category: Pharmaceuticals Source Type: news
Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience
Company Eligible to Receive Up to $43.75 Million in Milestones for Each IVR Candidate, Plus Royalties on Future Sales
BOSTON, April 25, 2018 -- (Healthcare Sales & Marketing Network) -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), a diversified healthc... Biopharmaceutical, Drug Delivery, Licensing Juniper Pharmaceuticals, Daré Bioscience, CRINONE, intravaginal ring (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 25, 2018 Category: Pharmaceuticals Source Type: news
Siemens nets FDA clearance for Edge Plus CT scanner
Siemens Healthineers has received U.S. Food and Drug Administration (FDA) clearance...Read more on AuntMinnie.comRelated Reading:
Siemens lands FDA clearance for Mammomat Revelation
Siemens Healthineers launches IPO, raising $5.2B
Siemens to debut portable cardiovascular US at ACC 2018
Siemens highlights Digital Ecosystem updates at HIMSS
New Siemens ECR 2018 products include Juniper ultrasound scanner (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 4, 2018 Category: Radiology Source Type: news
